Skip to main content
OpenTrials
Completed

NCT Number: NCT06354504

Bactericidal Permeability Protein Inhibitor and Interleukin-1beta Levels After Non-surgical Periodontal Treatment

The aim of this study was to examine the relationship between healing response after non-surgical periodontal treatment and baseline gingival crevicular fluid (GCF) levels of bactericidal/permeability-increasing protein (BPI) and interleukin-1beta (IL-1ß).

Completed

Looking for future studies?

Notify Me

Key information

Age range

22 year–64 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Akdeniz Üniversitesi Diş Hekimliği Fakültesi, Antalya, Turkey (Türkiye)

Loading trial locations.

About this study

Bactericidal/permeability-increasing proteins (BPI) specific and powerful effect against Gram negative bacteria and their LPSs is completely observable in biological fluids such as plasma, serum, and whole blood.

Objective: It is the evaluation of periodontal disease effect of BPI and interleukin-1 beta (IL-1 β) levels in gingival fluid before and after non-surgical periodontal treatment (NSPT)in patients with periodontal disease.

Method: Thirty systemically healthy and non-smoking individuals with periodontitis were included in the study. Before NSPT, the clinical parameters of plaque index (PI), gingival index (GI), probing depth (PD), clinical attachment level (CAS), bleeding on probing (BOP) were measured. The gingival fluid samples were taken using the paper strip method. The same procedures were repeated at 6 weeks and 6 months after non-surgical periodontal treatment. ELISA method was used for the analysis of the samples

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Systemically healthy,

  • Stage II or III, Grade A periodontitis
  • Having at least 20 permanent teeth (excluding third molars and any tooth loss induced by -non-periodontal causes).

Exclusion criteria

Smoking,

  • use of alcohol; pregnancy or lactation; intake ofantibiotics, steroidal or non-steroidal anti-inflammatory drugs within the last 6 months
  • having received periodontal treatment within the last 6 months

Treatment and study plan

Non-surgical periodontal treatment

Procedure

Scaling and root planing in two sessions over the course of a 48-hour period comprised the standard treatment procedure

Primary outcomes

  1. Gingival crevicular fluid Bactericidal/permeability-increasing proteins levels

    Time frame: through study completion, an average of 1 year

    Gingival Crevicular Fluid Bactericidal Permeability Increasing Protein levels in periodonitis patients after Non-surgical periodontal treatment

Secondary outcomes

  1. Gingival crevicular fluid interleukin-1Beta levels

    Time frame: through study completion, an average of 1 year

    Gingival Crevicular Fluid IL-1β in periodonitis patients after Non-surgical periodontal treatment

Sponsors and collaborators

Lead sponsor

Akdeniz University

Other

Registry information

Official study title

Gingival Crevicular Fluid (GCF) Bactericidal/Permeability-increasing Protein (BPI) and Interleukin (IL)-1beta in Periodontitis Patients: Non-surgical Periodontal Treatment Effects

Important dates

Study start
2019
Primary completion
2020
Study completion
2020
First posted
Apr 9, 2024
Registry last updated
Apr 9, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.